Lead development and execution of the WW autoimmune cell therapy medical affairs strategy for early assets, including annual and quarterly strategic planning, cross-functional alignment, and governance support to advance key program milestones
Serve as a strategic cross-functional medical affairs leader, partnering with Clinical Development, Commercial, Market Access, HEOR, and other stakeholders to drive coordinated execution, decision making, and operational excellence across priority initiatives
Support development of external medical education and capability-building initiatives that strengthen understanding of the potential of cell therapy in management of autoimmune diseases across relevant specialties and help address the evolving clinical practice needs
Partner with internal and external stakeholders to shape and execute evidence generation plans, including investigator-sponsored research, collaborative studies
Incorporate the patient perspective into medical affairs planning by collaborating with appropriate partners on patient insights, advocacy engagement, and unbranded educational initiatives that support awareness, access, and the patient care journey
Qualifications & Experience
Advanced, scientific or medical degree, e.g. DO, MD, NP, PA, PharmD, PhD
Minimum 5+ years experience in the pharma/biopharma industry or clinical practice
Advanced understanding of drug development, pharmaceutical and healthcare industries
Strong leadership experience in a matrix environment with multi-functional project teams and managing external agencies
Strong interpersonal communication skills commensurate with the need to work closely with both external physicians/scientists and in-house teams
Ability to navigate complex topics in a matrix environment with grace and confidence
Strong listening, problem solving, and prioritization skills
Excellent planning and organization skills including the ability to work under pressure, and to maintain scientific excellence within timelines
Excellent written and oral communication skills, including strong oral presentation skills
Ability to maintain the highest degree of confidentiality and integrity; representing the company's high ethics, moral behavior, and professionalism standards
HQ-based position with global travel expected up to 25%.
#LI-HYBRID
If you come across a role that intrigues you but doesn't perfectly line up with your resume, we encourage you to apply anyway. You could be one step away from work that will transform your life and career.
Compensation Overview:
Princeton - NJ - US: $207,490 - $251,433
Benefits
Health insuranceEquity / stock options
Additional Information
Working with Us
Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us .
Position Summary
The Director, Worldwide (WW) Autoimmune Cell Therapy Medical Affairs is a core member of the WW Medical team leading the medical strategy behind early CAR T assets in development for the treatment of autoimmune disease and driving execution of key zola-cel strategic initiatives. This individual will be a cross-functional leader within the Medical organization partnering closely with Clinical Development, Commercial, Market Access, and HEOR to advance early assets through key governance milestones and align on the medical strategy. As a member of the zola-cel team this individual will partner closely with key stakeholders to advance the medical strategy and realize the full potential of autologous CAR T for patients with autoimmune disease.